siRNA-mediated knockdown of Pdcd4 expression causes upregulation of p21(Waf1/Cip1) expression

Oncogene
N BitomskyK-H Klempnauer

Abstract

The transformation suppressor gene, programmed cell death gene 4 (Pdcd4), inhibits tumor-promoter-mediated transformation of mouse keratinocytes and has been implicated as a tumor suppressor gene in the development of human cancer. The Pdcd4 protein interacts with translation initiation factors eIF4A and eIF4G and binds to RNA, suggesting that it might be involved in regulating protein translation or other aspects of RNA metabolism. To study the function of Pdcd4 in more detail, we have downregulated Pdcd4 expression in HeLa cells by stable expression of shRNA. We have found that diminished Pdcd4 expression leads to increased expression of p21(Waf1/Cip1) and several other p53-regulated genes. Reporter gene studies demonstrate that Pdcd4 interferes with the activation of p53-responsive promoters genes by p53. Pdcd4 knockdown cells show decreased apoptosis and increased survival after UV irradiation. Taken together, our observations suggest a model in which low Pdcd4 expression after DNA damage favors the survival of cells, which would be eliminated by apoptosis under normal levels of Pdcd4 expression. Our results provide the first evidence that Pdcd4 is important role in the DNA-damage response and suggest that low levels of Pdc...Continue Reading

References

Mar 1, 1990·Molecular and Cellular Biology·F RozenN Sonenberg
Jan 12, 1989·Nature·P LinderP P Slonimski
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A J FornaceM C Hollander
Nov 19, 1993·Cell·W S el-DeiryB Vogelstein
Dec 16, 1993·Nature·Y XiongD Beach
Jan 1, 1997·Nature Genetics·Y X ZengW S el-Deiry
Apr 1, 1997·Genes & Development·J LaBaerE Harlow
Aug 22, 1997·International Journal of Cancer. Journal International Du Cancer·R ErberF X Bosch
Jul 1, 1999·Genes & Development·C J Sherr, J M Roberts
Nov 26, 1999·Proceedings of the National Academy of Sciences of the United States of America·J L CmarikN H Colburn
Apr 21, 2001·Oncogene·U SchlichterK H Klempnauer
Jan 10, 2002·Cell·C Prives, J L Manley
Sep 11, 2002·Biochemical and Biophysical Research Communications·Alexandra GökeYouhai H Chen
Jan 14, 2003·Trends in Molecular Medicine·Matthew R YoungNancy H Colburn
Jun 13, 2003·Oncogene·Hsin-Sheng YangNancy H Colburn
Nov 25, 2003·Biology of the Cell·Brigitte Lankat-Buttgereit, Rüdiger Göke
Aug 20, 2004·American Journal of Physiology. Cell Physiology·R GökeB Lankat-Buttgereit
Oct 29, 2004·Nature Reviews. Cancer·Ann M Bode, Zigang Dong
May 19, 2005·Cancer Research·Andrei L Gartel, Senthil K Radhakrishnan
Dec 17, 2005·Cancer Research·Alexey PalamarchukYuri Pekarsky
Jun 27, 2006·Oncogene·B W OzanneR F Hennigan
Oct 25, 2006·Molecular and Cellular Biology·Nicole LaRonde-LeBlancNancy H Colburn
Nov 23, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anja HilliardYouhai H Chen
Nov 28, 2006·Nature Reviews. Cancer·Franck Toledo, Geoffrey M Wahl

❮ Previous
Next ❯

Citations

Oct 29, 2011·The Journal of Biological Chemistry·Lena WedekenKarl-Heinz Klempnauer
Jan 21, 2010·Molecular and Cellular Biology·David ShahbazianNahum Sonenberg
Aug 13, 2010·Journal of Clinical Pathology·Matteo FassanMassimo Rugge
Jun 2, 2012·Frontiers in Bioscience (Landmark Edition)·Elodie LagesJean-Paul Issartel
Apr 29, 2009·World Journal of Gastroenterology : WJG·Hong FanYun-Feng Shan
Jun 8, 2013·World Journal of Gastroenterology : WJG·Stephane SupiotMichel Chérel
Jan 11, 2014·BMC Cell Biology·Dhanshri KakadeOlasunkanmi A J Adegoke
Jul 7, 2011·Proceedings of the National Academy of Sciences of the United States of America·Qingguo RuanYouhai H Chen
Nov 29, 2011·The International Journal of Biochemistry & Cell Biology·Tao WangYongping Su
Apr 10, 2009·Biology of the Cell·Brigitte Lankat-Buttgereit, Rüdiger Göke
Feb 27, 2014·Asian Pacific Journal of Cancer Prevention : APJCP·Xue DouDian-Bin Mu
Mar 5, 2013·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·Cui-Luan Yao, George N Somero
May 8, 2010·Journal of Hepatology·Changzheng LiuSongsen Chen
Jul 6, 2015·Archives of Biochemistry and Biophysics·Gang WangShing Shun Tony To
Sep 27, 2014·Biochimica Et Biophysica Acta·Mame Daro Faye, Martin Holcik
Sep 14, 2010·Cancer Cell·Mark E HatleyEric N Olson
Feb 1, 2012·Biochimica Et Biophysica Acta·Sebastian KrugBrigitte Lankat-Buttgereit
Oct 22, 2016·Current Research in Translational Medicine·Y LiuZ Wei
Mar 10, 2017·International Journal of Radiation Biology·Ye WangZhenyu Lin
Nov 8, 2018·Journal of Experimental & Clinical Cancer Research : CR·Ke-Ting QueZuo-Jin Liu
Feb 1, 2011·Virchows Archiv : an International Journal of Pathology·Matteo FassanMassimo Rugge
Dec 12, 2012·Virchows Archiv : an International Journal of Pathology·Kathrin LudwigMassimo Rugge
May 20, 2017·American Journal of Physiology. Lung Cellular and Molecular Physiology·David E GreenC Michael Hart
Jan 15, 2013·Oncology Reports·Peng-Tao GuoHui-Mian Xu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis